Direktorat Registrasi ObatValid

DAYVIGO

by '-'

Claim this product
BPOM Number
DKI2249600317A1
Approved
10 January 2025
Expiry
17 May 2027
Form
TABLET SALUT SELAPUT

About This Registration

DAYVIGO is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKI2249600317A1. Its current registration status is Valid, with the licence valid until 17 May 2027. The product is registered to EISAI INDONESIA - INDONESIA. BPOM first approved this registration in May 2022. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application
newaero
Packaging
DUS, 2 BLISTER @ 14 TABLET SALUT SELAPUT
Department
Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Market Intelligence

Owner Portfolio
EISAI INDONESIA - INDONESIA holds 34 BPOM registrations
Manufacturer Scale
EISAI INDONESIA - INDONESIA produces 34 registered products
Registration Age
Registered for 4 years, 2 months
Expiry Status
Expires in 10 months

FDA Cross-Reference

via openFDA
Generic Name
LEMBOREXANT
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product
1